Literature DB >> 35051611

FUNDC1 activates the mitochondrial unfolded protein response to preserve mitochondrial quality control in cardiac ischemia/reperfusion injury.

Haizhe Ji1, Jin Wang2, David Muid3, Wei Song1, Yinong Jiang4, Hao Zhou5.   

Abstract

The mitochondrial unfolded protein response (UPRmt) is an adaptive transcriptional response involving the activation of proteases, chaperones, and antioxidant enzymes and serves to degrade abnormal or unfolded proteins and restore mitochondrial function. Although the cardioprotective action of the UPRmt has been verified in myocardial ischemia/reperfusion (I/R) injuries, the upstream signals involved remain unclear. Here, we explored the regulatory mechanisms underlying UPRmt in the reperfused mouse heart. UPRmt was slightly activated by I/R injury. UPRmt activation (using oligomycin) and inhibition (with the protease inhibitor AEBSF) respectively alleviated and augmented the reperfusion-mediated myocardial damage. Gene expression analysis demonstrated that oxidative stress was partly inhibited by UPRmt through upregulation of mitochondria-localized, not cytoplasmic, antioxidant enzymes. Contributing to cardiomyocyte survival under I/R, the transcription of pro-apoptotic proteins Bcl2 and c-IAP was also stimulated by UPRmt. Moreover, UPRmt upregulated mitochondrial fusion-related, but not fission-related, genes and stimulated the expression of mitochondrial biogenesis markers in reperfused hearts. Finally, we found that FUN14 domain containing 1 (FUNDC1)-mediated mitophagy induces the mitochondrial DNA decrease, triggering UPRmt. These results demonstrate that FUNDC1 functions upstream of the UPRmt to maintain mitochondrial quality control during myocardial I/R injury.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte; FUNDC1; Mitochondrial unfolded protein response; Mitophagy; Myocardial I/R injury

Mesh:

Substances:

Year:  2022        PMID: 35051611     DOI: 10.1016/j.cellsig.2022.110249

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

1.  ERK/HIF-1α/VEGF pathway: a molecular target of ELABELA (ELA) peptide for attenuating cardiac ischemia-reperfusion injury in rats by promoting angiogenesis.

Authors:  Kamran Rakhshan; Masoomeh Sharifi; Fatemeh Ramezani; Yaser Azizi; Nahid Aboutaleb
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

Review 2.  Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products.

Authors:  Xin Su; Mingyang Zhou; Yingjian Li; Na An; Fan Yang; Guoxia Zhang; Lianjiang Xu; Hengwen Chen; Hongjin Wu; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2022-05-16       Impact factor: 7.310

Review 3.  The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy.

Authors:  Li-Chan Tao; Ting-Ting Wang; Lu Zheng; Fei Hua; Jian-Jun Li
Journal:  Biomol Ther (Seoul)       Date:  2022-04-12       Impact factor: 4.231

Review 4.  The Mitochondrial Unfolded Protein Response: A Novel Protective Pathway Targeting Cardiomyocytes.

Authors:  Jinfeng Liu; Xinyong He; Sicheng Zheng; Aisong Zhu; Junyan Wang
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.